![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 49, 46160-46164, December 7, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
**, and

From the
Department of Biology, McGill University,
1205 Avenue Dr. Penfield, Montréal, Québec H3A 1B1,
Canada, § Department of Biomedical Chemistry, Graduate
School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan, ¶ Department of Biochemistry, McGill University, 3655 Promenade Sir William Osler, Montréal, Québec
H3G 1Y6, Canada, and
Montreal Neurological Institute and
Department of Human Genetics, McGill University, 3801 University
Street, Montréal, Québec H3A 2B4, Canada
Received for publication, September 17, 2001, and in revised form, October 2, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Ubiquinone (UQ) is a lipid found in most
biological membranes and is a co-factor in many redox processes
including the mitochondrial respiratory chain. UQ has been implicated
in protection from oxidative stress and in the aging process.
Consequently, it is used as a dietary supplement and to treat
mitochondrial diseases. Mutants of the clk-1 gene of the
nematode Caenorhabditis elegans are fertile and have an
increased life span, although they do not produce UQ but instead
accumulate a biosynthetic intermediate, demethoxyubiquinone (DMQ). DMQ
appears capable to partially replace UQ for respiration in
vivo and in vitro. We have produced a vertebrate
model of cells and tissues devoid of UQ by generating a knockout
mutation of the murine orthologue of clk-1
(mclk1). We find that mclk1 clk-1 mutants of Caenorhabditis elegans are
being studied for their pleiotropic phenotype, in which the rates of
many biological processes are deregulated and slowed down on average
(1, 2). clk-1 encodes a highly conserved (3, 4)
mitochondrial (5, 6) protein that is required for ubiquinone
(UQ)1 biosynthesis in yeast
(7) and worms (8, 9). Recent evidence suggests that CLK-1 is a
hydroxylase that converts demethoxyubiquinone (DMQ) into 5-hydroxy-UQ
(10). Indeed, a bacterial CLK-1 homologue is capable of replacing the
function of UbiFp, the unrelated enzyme that carries out this function
in Escherichia coli. Consistent with this finding,
clk-1 mutants in yeast and worms accumulate DMQ9
instead of producing UQ9 (7, 9) (the subscript refers to
the length of the isoprenoid side chain). In E. coli,
DMQ8 is able to sustain respiration in isolated membranes
although at a lower rate than Q8 (11). Similarly,
DMQ9 also appears to be capable of sustaining electron
transport in clk-1 mutants at almost wild-type levels (6,
9). Furthermore, synthetic DMQ2 can function as a co-factor
for electron transport from Complex I and, albeit more poorly, from
Complex II (9).
It is not clear how the absence of UQ relates to the other phenotypes
of clk-1 mutants as there is no correlation between the
biochemical phenotype and the severity of the overall phenotype. Indeed, the quinone phenotype is identical for all three known clk-1 alleles (e2519, qm30, and
qm51); UQ9 is undetectable in the mitochondria
in all three cases, and all three accumulate the same amount of DMQ.
Yet, most of the features affected in clk-1 mutants are
slowed down much more severely in the putative null alleles
qm30 and qm51 than they are in the partial loss
of function allele e2519 (1, 6).
Recently, it has been found that clk-1 mutants are unable to
grow on a UQ-deficient bacterial strain despite the presence and the
activity of DMQ9 (8). This has been interpreted to suggest
that DMQ9 is insufficient for normal mitochondrial function and that dietary bacterial UQ8 can reach the mitochondria
and function there in trace amounts (8). However, dietary UQ is generally not capable of reaching mitochondria, at least in vertebrates (reviewed in Ref. 12), and DMQ appears to be capable of functionally replacing UQ in the respiratory chain. An alternative possibility is
that UQ is necessary for viability at other sites than the respiratory
chain. To investigate further the function of CLK-1 and the biological
roles of UQ, we have generated a knockout mutation of the murine
orthologue of clk-1. Our study of ubiquinone biosynthesis and function in mutant embryos and ES cell lines allowed us to resolve
some of the questions raised by the work on clk-1 in worms and yeast.
Construction of the Targeting Vector and ES Cell
Transfection--
An lFIX II genomic library from mouse strain 129/SvJ
DNA (Stratagene) was screened with a genomic mclk1 fragment,
and six overlapping genomic clones were obtained. Genomic DNA fragments from two clones were subcloned into Bluescript SK and characterized in
detail. A 7-kb NotI-BamHI fragment containing
part of the mclk1 promoter and exons I, II, and III was
subcloned into Bluescript SK (pL5). A 1.6-kb fragment containing part
of exons II and III was removed from pL5 by
StuI-BamHI digestion and replaced with a neomycin
cassette consisting of a 1.1-kb XhoI
blunted-BamHI fragment from pMC1Neo poly(A) to produce
pL5+Neo. A 2.8-kb PstI-SacI genomic fragment
containing introns IV and V and 500 bp from the 5'-untranslated region
was subcloned in Bluescript (pL15). A 2.5-kb EcoRV-XhoI fragment from pL15 was inserted into
the SmaI-XhoI sites of pL5+Neo to produce the
final replacement targeting vector pL17. A KpnI fragment
from the targeting vector was isolated and electroporated into R1 ES
cells. Two thousand G418-resistant clones were analyzed by
Southern blot analysis. Genomic DNA was digested with BglII
and then hybridized with a 3'-external probe flanking the 3' region of
the targeting vector (SacI-XhoI fragment). After analyzing the promising neomycin-resistant clones by extensive Southern
blot, four clones showed homologous recombinants. We used
two independently targeted ES cell clones with the correct karyotype to
generate mclk1 Genotype Determination--
DNA was prepared from tails of adult
mice or yolk sacs of embryos. Southern blot analysis was done as
described above. Polymerase chain reaction was done for 30 cycles
(95 °C, 30 s; 58 °C, 30 s; 72 °C, 30 s). The
primers used to detect the wild-type mclk1 allele were as
follows: forward (KO5), 5'-ggt gaa gtc ttt tgg gtt tga gca t-3';
reverse (KO6), 5'-tgt cta agg tca tcc ccg aac tgt g-3'. They amplify a
product of 302 bp. The targeted mclk1 allele was detected
with the primers KO7 (5'-gcc agc gat atg act cag tgg gta a-3') and KO8
(5'-cac ctt aat atg cga agt gga cct g-3'), which give a product of 397 bp.
Northern and Western Blotting--
Northern analysis was
performed using the full-length mclk1 cDNA as a probe as
described (13). Western blots were performed using monoclonal
antibodies against cytochrome c oxidase subunits I
(1D6-E1-A8) and IV (20E8-C12) from Molecular Probes and against human
porin 31HL from Calbiochem.
Preparation of Cell-free Extracts for Quinone Analysis and Enzyme
Activity Measurements--
The samples were homogenized in 50 mM potassium phosphate buffer (pH 7.4) and centrifuged at
1,000 × g for 5 min at 4 °C. The supernatants were
used to determine quinone content and to measure enzyme activity.
Protein concentration was determined with bovine serum albumin as the
standard (14).
Identification of Quinones--
Quinones were extracted as
described (9), with slight modifications. Briefly, the quinones
extracted in n-hexane/EtOH were dried under nitrogen gas,
dissolved in acetone, and left at Enzyme Assays--
All of the assays were performed in 50 mM potassium phosphate buffer (pH 7.4) at 25 °C.
NADH-cytochrome c reductase activity and
succinate-cytochrome c reductase activity were assayed as described (9). NADH-ferricyanide reductase activity was measured in the
presence of 200 µM NADH and 1.3 mM potassium
ferricyanide (Sigma) by monitoring the absorbance change of potassium
ferricyanide at 420 nm using an extinction coefficient of 1.0 mM Establishment of ES Cell Lines--
Wild-type, heterozygous, and
homozygous ES cell lines were established using a standard procedure
(15).
Polarography/Oxygen Consumption--
Oxygen consumption was
measured as described previously (16) in mclk1 +/+, +/ To further study the function of CLK-1 and the biological roles of
ubiquinone, we disrupted the mclk1 locus in murine ES cells by homologous recombination and produced heterozygous and homozygous mice using standard methods (see "Experimental Procedures" and Figs. 1 and 2, c and
d). Heterozygous +/
/
embryonic
stem cells and embryos accumulate DMQ instead of UQ. As in the
nematode mutant, the activity of the mitochondrial respiratory chain of
/
embryonic stem cells is only mildly affected (65% of wild-type
oxygen consumption). However, mclk1
/
embryos arrest development at midgestation, although earlier developmental stages appear normal. These findings indicate that UQ is necessary for vertebrate embryonic development but suggest that mitochondrial respiration is not the function for which UQ is essential when DMQ is present.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
mice.
80 °C. After 30 min, the samples
were centrifuged at 17,000 × g for 15 min at 4 °C,
and the supernatant was dried under nitrogen gas. The residue was
dissolved in EtOH, vortexed for 2 min, and applied to HPLC equipped
with a guard column, an analytical column (Inertsil ODS-3, C-18, 5 µm, 4.6 × 250 mm, GL Science, Tokyo), and a reduction column
(Type RC-10, Irica, Kyoto, Japan). The mobile phase was 50 mM sodium percholorate in
tetrahydrofuran/MeOH/H2O (107/125/18, v/v) with a flow rate
of 0.5 ml/min. The elution was monitored by a photodiode array
UV-visible detector (Shimadzu SPD10-A) at 275 nm and an amperometric
electrochemical detector (ECD, Nanospace SI-2/3005, Shiseido, Tokyo).
The oxidation potential for ECD was 600 mV on a glassy carbon
electrode. The concentration of quinones was determined
spectrophotometrically as described (9) or by ECD. The data were
analyzed by Shimadzu Class-VP software (version 5.03).
1 cm
1.
,
and
/
ES cells.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
mice are viable and fertile. They show no obvious anatomical
or behavioral defects. However, after crossing heterozygous male and
female mice, no newborn
/
mice were observed in more than 81 offspring (Table I), indicating that
homozygous disruption of mclk1 results in embryonic
lethality. To determine the timing of the lethality, embryos from
heterozygous intercrosses were analyzed at different days of gestation
(Table I). mclk1
/
embryos were present at expected Mendelian frequencies at day 8.5 postcoitum (E8.5). By E13.5,
however, all mclk1
/
embryos detected were in the
process of being resorbed. The homozygous embryos showed a
developmental delay that is clearly evident by E9.5 (Fig.
3).

View larger version (10K):
[in a new window]
Fig. 1.
Maps of the wild-type mclk1
locus and of the targeting vector. The black
boxes represent exons. The targeting vector consists of the
replacement of a part of exon II and exons III and IV by the neomycin
gene (white box). A, BamHI;
B, BglII; E, EcoRI;
K, KpnI; R, EcoRV;
S, SacI; X, XhoI.

View larger version (53K):
[in a new window]
Fig. 2.
Targeted disruption of the mouse
mclk1 gene. a, Northern blot analyses
of total RNA levels in tissues from mclk1 +/+ and +/
mice
and from E11.5 mclk1 +/+, +/
, and
/
littermates. The
expression level of the mitochondrially encoded cox1, which
codes for a subunit of cytochrome c oxidase (Complex IV), is
shown as one of the controls. The expression level of cox1
serves as a measure of the capacity for oxidative phosphorylation in a
given tissue. The decreased level observed in homozygous embryos is
likely to be due to the beginning of the resorption process.
b, Western blot analyses of protein levels in tissues from
mclk1 +/+ and +/
mice. Total protein extracts from the
liver and brain of 2 -day-old mice were probed with antibodies against
mCLK1, COX1, and porin. Porin is a protein of the outer mitochondrial
membrane encoded in the nucleus. c, genotype analysis
of embryos by polymerase chain reaction using two mixes of primers (see
"Experimental Procedures"). The upper band (397 bp) is
specific for the wild-type mclk1 allele, and the lower
band (302 bp) is specific for the mutant allele. Mut,
mutant; Wt, wild type. d, Southern blot analysis.
DNA of E9.5 embryos from intercross of mclk1 +/
mice was
digested with BglII, electrophoresed on agarose gel,
blotted, and hybridized with a 3'-external probe
(XhoI-SacI fragment). This probe hybridized to a
3.7-kb band in BglII digests of the native gene and an
8.2-kb band in the disrupted gene.
Genotype distribution from mclk1 heterozygous crosses

View larger version (56K):
[in a new window]
Fig. 3.
Severe developmental delay in
mclk1 mutant embryos. a, gross
morphology of +/
and
/
embryos. The embryos are at E10.5 and are
littermates. T, telencephalon; M, mesencephalon;
Aa, forelimb bud; So, somites; Vg,
visceral groove; H, heart; Oc, otic vesicle;
1, first arch; 2, second arch. b, c,
and d, histological sections of mclk1
/
embryos at E10.5 stained with hematoxylin and eosin. No obvious
specific developmental defects were observed. At E10.5, wild-type
embryos have 30-35 somites, and many internal structures can be
discerned such as the visceral arches, the heart, the liver, and a
rudimentary mesonephros. The size, the number of somites (15-20), and
the structural organization of mclk1
/
embryos resemble
those of the wild-type embryos at earlier stages of development (here,
around E9).
Northern blot analysis of total E11.5 embryo RNA showed that the amount
of mclk1 mRNA was reduced by ~50% in heterozygous embryos compared with normal embryos and could not be detected in
mclk1
/
embryos (Fig. 2a). A ~50% decrease
of mclk1 transcript was observed in several tissues of
44-day-old mclk1 +/
mouse compared with wild-type
littermates (Fig. 2a). Immunoblotting with a polyclonal
antibody (13) revealed a band of ~ 21 kDa in liver and brain
extracts from +/+ and +/
mice. This signal was reduced by 50% in
extracts from +/
mice compared with that from +/+ mice (Fig.
2b). The results confirm that the mclk1 mutation is a null mutation and demonstrated a gene-dosage effect on protein levels in +/
mice.
The amounts of ubiquinone-9 (UQ9) and -10 (UQ10) in homogenates of mclk1 +/+, +/
, and
+/
embryos were determined by HPLC (Fig.
4a). For mclk1 +/+
embryos, a major peak elutes at 42.4 min and is identical to standard
UQ9 for elution time. A smaller peak that elutes around 57 min corresponds to UQ10. The quinone profile of
mclk1 +/
embryos is indistinguishable from that of the
wild type. The amounts of UQ9 and UQ10 were
similar in wild-type and heterozygous embryos (Table
II). However, neither UQ9 nor UQ10 was detected in mclk1
/
embryos (Fig.
4a and Table II). These mutant embryos instead
exhibited a major peak eluting 2.3 min earlier than UQ9.
This component co-eluted with DMQ9 purified from
clk-1 mutant C. elegans (9).
|
|
mclk1 +/+, +/
, and
/
ES cell lines were derived from
E3.5 blastocysts obtained from heterozygous matings. The profiles and
concentrations of quinones in these lines were very similar to those
observed in the genetically equivalent embryos (Fig. 4b;
Table II). In particular, only DMQ9 was detected in the
mclk1
/
ES cell line (ES-7) (Fig.
4b).
We used the ES cell lines to study the effect of the UQ deficiency on the function of mitochondrial enzymes and overall cellular oxygen consumption (Table III). The activity of succinate cytochrome c reductase, for which UQ is a required co-factor and involves respiratory Complexes II and III, is severely reduced (15% of wild type). However, the activity of NADH-cytochrome c reductase, which involves the activity of Complex I and Complex III, is not very strongly affected (63% of wild type). As a control, we measured the activity of NADH-ferricyanide reductase, which involves subunits of Complex I but is not believed to require UQ (17, 18). As expected, NADH-ferricyanide reductase remains unaffected in the mutant cells (Table III). Consistent with the above observations, we find that the overall level of oxygen consumption in the mutants is reduced relatively little, to 65% of wild type, which parallels the moderate reduction in the activities of Complexes I and III (Table III).
|
| |
DISCUSSION |
|---|
|
|
|---|
Our results show that UQ is not made in mclk1 knockout embryos and ES cells. Instead, DMQ accumulates in levels very similar to those of UQ in wild-type embryos or cells. UQ is a co-factor in the function of the respiratory chain in transporting electrons from Complexes I and II to Complex III. However, we find that the functions of Complexes I and III, as well as overall respiration, are relatively mildly impaired in mclk1 cells. In contrast, the function of Complex II in electron transport is much more severely affected. Similar observations have been made in other organisms such as E. coli and C. elegans, in which DMQ is capable of replacing UQ in Complexes I and III but is a relatively poor acceptor of electrons from succinate (9, 11). Note, however, that in worm clk-1 mutants that produce only DMQ, succinate cytochrome c reductase appears to be less affected (6, 9) than what we observed in the ES cell lines.
Thus, as in the case of the clk-1 mutants in C. elegans, the DMQ produced in mclk1 mutants appears to be sufficient for the maintenance of a relatively high level of mitochondrial function (65% of wild-type oxygen consumption). In C. elegans, it has been argued that the maintenance of mitochondria activity could be because of dietary UQ8 acquired from the bacterial food source (8). This hypothesis is based on the observation that clk-1 mutant worms cannot grow on bacteria that do not synthesize UQ. However, this cannot be the explanation for the high oxygen consumption in the mclk1 ES cells, as we used charcoal-depleted serum and could not find any trace of UQ in this serum by HPLC (data not shown). It is highly unlikely therefore that any exogenous UQ is responsible for the level of oxygen consumption we observed in the mclk1 cells.
It is surprising that the levels of mitochondrial function found in the
mclk1 mutant cells are insufficient to carry out
embryogenesis. This observation is similar to the unexpected finding
that dietary UQ is necessary for C. elegans clk-1 mutant
development despite the presence of high level of active mitochondrial
DMQ. One possibility is that embryogenesis in both organisms requires
UQ at other sites in addition to the respiratory chain. UQ is found in
almost all biological membranes (12) and is known to be a co-factor of the uncoupling proteins in the mitochondria (19, 20), to regulate the
permeability transition pore (21), and to function in plasma membrane
and lysosomal oxidoreductase systems (22, 23). UQ is also a co-factor
for a number of cellular enzymes, including glycerol 3-phosphate
dehydrogenase, dihydroorotate reductase, and ETF (electron-transferring
flavoprotein):ubiquinone reductase. Furthermore, it has recently been
discovered that, in bacteria, respiratory quinones are the primary
signal for the regulation of growth in response to oxygen availability
(24). Given the conservation between prokaryotes and eukaryotes of
crucial molecular mechanisms that sense environmental signals
(e.g. the PAS domain proteins) (25), the complete UQ
deficiency in mclk1 mutants could directly affect the
regulation of embryonic growth. Note that although quinone contents are
higher in tissues like heart, there is no evidence for tissue-specific
abnormalities in early development. Had development proceeded
further, it is possible that such effects would have been exposed. In
conclusion, although we have shown that DMQ can replace UQ in the
respiratory chain, it is possible that DMQ is unable to replace UQ for
one or more of its functions at other sites.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Abdelmadjid Hihi, Claire Bénard, and Robyn Branicky for critically reading the manuscript and Josée Breton for expert technical assistance.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** A Montreal Neurological Institut Killam scholar.

A Canadian Institutes of Health Research scientist. To
whom correspondence should be addressed. Tel.: 514-398-6440; Fax:
514-398-1674; E-mail: Siegfried.Hekimi@McGill.ca.
Published, JBC Papers in Press, October 3, 2001, DOI 10.1074/jbc.M108980200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: UQ, ubiquinone; DMQ, demethoxyubiquinone; ES cell, embryonic stem cell; kb, kilobase pair(s); bp, base pair(s); HPLC, high pressure liquid chromatography; ECD, electrochemical detector; E, embryonic day (e.g. E10.5).
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Wong, A., Boutis, P., and Hekimi, S. (1995) Genetics 139, 1247-1259[Abstract] |
| 2. | Branicky, R., Benard, C., and Hekimi, S. (2000) Bioessays 22, 48-56[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Ewbank, J. J.,
Barnes, T. M.,
Lakowski, B.,
Lussier, M.,
Bussey, H.,
and Hekimi, S.
(1997)
Science
275,
980-983 |
| 4. | Hekimi, S. (2000) Results Probl. Cell Differ. 29, 81-112[Medline] [Order article via Infotrieve] |
| 5. |
Jonassen, T.,
Proft, M.,
Randez-Gil, F.,
Schultz, J. R.,
Marbois, B. N.,
Entian, K. D.,
and Clarke, C. F.
(1998)
J. Biol. Chem.
273,
3351-3357 |
| 6. | Felkai, S., Ewbank, J. J., Lemieux, J., Labbe, J. C., Brown, G. G., and Hekimi, S. (1999) EMBO J. 18, 1783-1792[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Marbois, B. N.,
and Clarke, C. F.
(1996)
J. Biol. Chem.
271,
2995-3004 |
| 8. |
Jonassen, T.,
Larsen, P. L.,
and Clarke, C. F.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
421-426 |
| 9. |
Miyadera, H.,
Amino, H.,
Hiraishi, A.,
Taka, H.,
Murayama, K.,
Miyoshi, H.,
Sakamoto, K.,
Ishii, N.,
Hekimi, S.,
and Kita, K.
(2001)
J. Biol. Chem.
276,
7713-7716 |
| 10. |
Stenmark, P.,
Grunler, J.,
Mattsson, J.,
Sindelar, P. J.,
Nordlund, P.,
and Berthold, D. A.
(2001)
J. Biol. Chem.
276,
33297-33300 |
| 11. | Wallace, B. J., and Young, I. G. (1977) Biochim. Biophys. Acta 461, 75-83[Medline] [Order article via Infotrieve] |
| 12. | Dallner, G., and Sindelar, P. J. (2000) Free Radic. Biol. Med. 29, 285-294[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Jiang, N.,
Levavasseur, F.,
McCright, B.,
Shoubridge, E.,
and Hekimi, S.
(2001)
J. Biol. Chem.
276,
29218-29225 |
| 14. |
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275 |
| 15. | Auerbach, W., Dunmore, J. H., Fairchild-Huntress, V., Fang, Q., Auerbach, A. B., Huszar, D., and Joyner, A. L. (2000) BioTechniques 29, 1024-1028[Medline] [Order article via Infotrieve], 1030, 1032 |
| 16. | Scott, A. E., Cosma, G. N., Frank, A. A., Wells, R. L., and Gardner, H. S., Jr. (2001) Toxicol. Appl. Pharmacol. 171, 149-156[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Ackrell, B. A. C., Johnson, M. K., Gunsalus, R. P., and Cecchini, G. (1992) in Chemistry and Biochemistry of Flavoenzymes (Muller, F., ed), Vol. III , pp. 229-297, CRC Press, London |
| 18. | Walker, J. E., Skehel, J. M., and Buchanan, S. K. (1995) Methods Enzymol. 260, 14-34[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Echtay, K. S., Winkler, E., and Klingenberg, M. (2000) Nature 408, 609-613[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
Echtay, K. S.,
Winkler, E.,
Frischmuth, K.,
and Klingenberg, M.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
1416-1421 |
| 21. |
Fontaine, E.,
Ichas, F.,
and Bernardi, P.
(1998)
J. Biol. Chem.
273,
25734-25740 |
| 22. | Gille, L., and Nohl, H. (2000) Arch. Biochem. Biophys. 375, 347-354[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Santos-Ocana, C., Villalba, J. M., Cordoba, F., Padilla, S., Crane, F. L., Clarke, C. F., and Navas, P. (1998) J. Bioenerg. Biomembr. 30, 465-475[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Georgellis, D.,
Kwon, O.,
and Lin, E. C.
(2001)
Science
292,
2314-2316 |
| 25. | Gu, Y. Z., Hogenesch, J. B., and Bradfield, C. A. (2000) Annu. Rev. Pharmacol. Toxicol. 40, 519-561[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
B. Lu, C. Poirier, T. Gaspar, C. Gratzke, W. Harrison, D. Busija, M. M. Matzuk, K.-E. Andersson, P. A. Overbeek, and C. E. Bishop A Mutation in the Inner Mitochondrial Membrane Peptidase 2-Like Gene (Immp2l) Affects Mitochondrial Function and Impairs Fertility in Mice Biol Reprod, April 1, 2008; 78(4): 601 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Branicky, P. A. T. Nguyen, and S. Hekimi Uncoupling the Pleiotropic Phenotypes of clk-1 with tRNA Missense Suppressors in Caenorhabditis elegans Mol. Cell. Biol., May 15, 2006; 26(10): 3976 - 3985. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Aguilaniu, J. Durieux, and A. Dillin Metabolism, ubiquinone synthesis, and longevity Genes & Dev., October 15, 2005; 19(20): 2399 - 2406. [Full Text] [PDF] |
||||
![]() |
X. Liu, N. Jiang, B. Hughes, E. Bigras, E. Shoubridge, and S. Hekimi Evolutionary conservation of the clk-1-dependent mechanism of longevity: loss of mclk1 increases cellular fitness and lifespan in mice Genes & Dev., October 15, 2005; 19(20): 2424 - 2434. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Padilla, T. Jonassen, M. A. Jimenez-Hidalgo, D. J. M. Fernandez-Ayala, G. Lopez-Lluch, B. Marbois, P. Navas, C. F. Clarke, and C. Santos-Ocana Demethoxy-Q, An Intermediate of Coenzyme Q Biosynthesis, Fails to Support Respiration in Saccharomyces cerevisiae and Lacks Antioxidant Activity J. Biol. Chem., June 18, 2004; 279(25): 25995 - 26004. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Burgess, A. K. Hihi, C. Y. Benard, R. Branicky, and S. Hekimi Molecular Mechanism of Maternal Rescue in the clk-1 Mutants of Caenorhabditis elegans J. Biol. Chem., December 5, 2003; 278(49): 49555 - 49562. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Hihi, H. Kebir, and S. Hekimi Sensitivity of Caenorhabditis elegans clk-1 Mutants toUbiquinone Side-chain Length Reveals Multiple Ubiquinone-dependent Processes J. Biol. Chem., October 17, 2003; 278(42): 41013 - 41018. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hekimi and L. Guarente Genetics and the Specificity of the Aging Process Science, February 28, 2003; 299(5611): 1351 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jonassen, B. N. Marbois, K. F. Faull, C. F. Clarke, and P. L. Larsen Development and Fertility in Caenorhabditis elegans clk-1 Mutants Depend upon Transport of Dietary Coenzyme Q8 to Mitochondria J. Biol. Chem., November 15, 2002; 277(47): 45020 - 45027. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Hihi, Y. Gao, and S. Hekimi Ubiquinone Is Necessary for Caenorhabditis elegans Development at Mitochondrial and Non-mitochondrial Sites J. Biol. Chem., January 11, 2002; 277(3): 2202 - 2206. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |